Risks of hepatitis C virus reactivation in a real-life population of oncology patients treated in an academic center.

Catherine-Audrey Boutin Jean-Philippe AdamDominic MartelStéphane DoucetValérie Martel-Laferrière

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

We identified a very small number of HCV cases among our population. We observed HCVr and hepatic flares, but only one consequence on cancer treatment. Nonetheless, HCV screening is encouraged among patients undergoing chemotherapy to allow close follow-up of hepatic function.

Keyphrases

hepatitis c virus
human immunodeficiency virus
patients undergoing
palliative care
squamous cell carcinoma
locally advanced
risk assessment
rectal cancer
chemotherapy induced